Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress in understanding and treating Parkinson's disease

A Barbeau

    The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
    |May 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Pathogenesis of Parkinson's Disease.

    Canadian Medical Association journal·2010
    Same author

    Beta cell compensation for insulin resistance in Zucker fatty rats: increased lipolysis and fatty acid signalling.

    Diabetologia·2006
    Same author

    [Reactions of social workers in a mental health day center and the avoidance of institutionalization of individual defense mechanisms].

    Sante mentale au Quebec·1992
    Same author

    [Clinical reflections on the setting up of a residence for social reinsertion of schizophrenics].

    Sante mentale au Quebec·1992
    Same author

    Dominantly inherited ataxias in Portugal.

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·1988
    Same author

    Linkage studies of Friedreich ataxia by means of blood-group and protein markers.

    American journal of human genetics·1987

    This review examines Levodopa therapy

    Area of Science:

    • Neurology
    • Pharmacology

    Background:

    • Parkinson's disease is a neurodegenerative disorder affecting motor function.
    • Levodopa is a primary treatment, but long-term effects require evaluation.

    Purpose of the Study:

    • To assess the long-term impact of Levodopa on Parkinson's disease patients' quality of life, survival, and mortality.
    • To review current and emerging therapeutic strategies for Parkinson's disease.

    Main Methods:

    • Literature review of studies on Levodopa therapy in Parkinson's disease.
    • Analysis of data on quality of life, survival rates, and mortality.
    • Evaluation of combination therapies and novel agents.

    Main Results:

    • Long-term Levodopa therapy influences quality of life and survival outcomes in Parkinson's disease.

    Related Experiment Videos

  • Combination therapies (Levodopa with Dopa-decarboxylase inhibitors or MAO-B inhibitors) and dopamine agonists offer alternative treatment options.
  • Novel compounds like MIF-I are under investigation.

    • Conclusions:

    • Levodopa's long-term effects on Parkinson's disease patients are multifaceted.
    • Emerging therapies and etiological research, including accelerated neuronal aging, are crucial for future Parkinson's disease management.